The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Prospective Trial of an Endoscopic Quality Improvement Project
Official Title: A Prospective Randomized Controlled Trial of an Endoscopic Quality Improvement Project-2 (EQUIP-2) to Improve Adenoma Detection in Screening and Surveillance Colonoscopy
Study ID: NCT02325635
Brief Summary: Randomized prospective multi-site validation study.
Detailed Description: GI practice sites that have recently agreed to participate in the GIQuIC program will be randomized on a site-basis, to the EQUIP intervention or control. Baseline ADR and polyp/surveillance predication accuracy will be collected for approximately 3 months. Sites randomized to the EQUIP intervention will undergo face-to-face training by a study investigator, followed by active monitoring and feedback. Control sites will not receive supplemental training and will be monitored by with no feedback. After completion of the study all sites will be offered the intervention (as is standard feedback in GIQuIC ).
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Mayo Clinic Florida, Jacksonville, Florida, United States
Name: Michael Wallace, MD
Affiliation: Mayo Clinic
Role: PRINCIPAL_INVESTIGATOR